Multiplicity and plasticity of natural killer cell signaling pathways

Blood

Volumn 107, Issue 6, 2006, Pages 2364-2372

  Chiesa, Sabrina ^b   Mingueneau, Michael ^b   Fuseri, Nicolas ^b   Malissen, Bernard ^b   Raulet, David H ^b   Malissen, Marie ^b   Vivier, Eric ^a   Tomasello, Elena ^a  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LAT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; GENE MUTATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 33644751667     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-08-3504     Document Type: Article

References (63)

1. Hoglund P, Sundback J, Olsson-Alheim MY, et al. Host MHC class I gene control of NK-cell specificity in the mouse. Immunol Rev. 1997;155:11-28.
2. Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L. What is a natural killer cell? Nat Immunol. 2002;3:6-8.
3. Yokoyama WM, Plougastel BF. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol. 2003;3:304-316.
4. Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:225-274.
5. Moretta L, Bottino C, Pende D, Mingari MC, Biassoni R, Moretta A. Human natural killer cells: their origin, receptors and function. Eur J Immunol. 2002;32:1205-1211.
6. Vivier E, Nunes JA, Vely F. Natural killer cell signaling pathways. Science. 2004;306:1517-1519.
7. Vivier E, Daëron M. Immunoreceptor tyrosine-based inhibition motifs (ITIMs). Immunol Today. 1997;18:286-291.
8. Tomasello E, Vivier E. KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions. Eur J Immunol. 2005;35:1670-1677.
9. Moretta L, Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 2004;23:255-259.
10. Arnon TI, Lev M, Katz G, Chernobrov Y, Porgador A, Mandelboim O. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol. 2001;31:2680-2689.
11. Mandelboim O, Lieberman N, Lev M, et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature. 2001;409:1055-1060.
12. Arnon TI, Achdout H, Levi O, et al. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol. 2005;6:515-523.
13. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol. 2003;3:781-790.
14. Gasser S, Orsulic S, Brown EJ, Raulet DH. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature. 2005;436:1186-1190.
15. Diefenbach A, Tomasello E, Lucas M, et al. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat Immunol. 2002;3:1142-1149.
16. Gilfillan S, Ho EL, Cella M, Yokoyama WM, Colonna M. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat Immunol. 2002;3:1150-1155.
17. Sjolin H, Tomasello E, Mousavi-Jazi M, et al. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J Exp Med. 2002;195:825-834.
18. Colucci F, Di Santo JP, Leibson PJ. Natural killer cell activation in mice and men: different triggers for similar weapons? Nat Immunol. 2002;3:807-813.
19. MacFarlane AW IV, Campbell KS. Signal transduction in natural killer cells. Curr Top Microbiol Immunol. 2006;298:23-57.
20. Tomasello E, Olcese L, Vely F, et al. Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)/DAP-12. J Biol Chem. 1998;273:34115-34119.
21. McVicar DW, Taylor LS, Gosselin P, et al. DAP12-mediated signal transduction in natural killer cells: a dominant role for the syk protein-tyrosine kinase. J Biol Chem. 1998;273:32934-32942.
22. Colucci F, Schweighoffer E, Tomasello E, et al. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nat Immunol. 2002;3:288-294.
23. Brdicka T, Imrich M, Angelisova P, et al. Non-T cell activation linker (NTAL): a transmembrane adaptor protein involved in immunoreceptor signaling. J Exp Med. 2002;196:1617-1626.
24. Janssen E, Zhu M, Zhang W, Koonpaew S. LAB: a new membrane-associated adaptor molecule in B cell activation. Nat Immunol. 2003;4:117-123.
25. Rivera J. NTAL/LAB and LAT: a balancing act in mast-cell activation and function. Trends Immunol. 2005;26:119-122.
26. Togni M, Lindquist J, Gerber A, et al. The role of adaptor proteins in lymphocyte activation. Mol Immunol. 2004;41:615-630.
27. Jordan MS, Singer AL, Koretzky GA. Adaptors as central mediators of signal transduction in immune cells. Nat Immunol. 2003;4:110-116.
28. Zhang W, Sommers CL, Burshtyn DN, et al. Essential role of LAT in T cell development. Immunity. 1999;10:323-332.
29. Volna P, Lebduska P, Draberova L, et al. Negative regulation of mast cell signaling and function by the adaptor LAB/NTAL. J Exp Med. 2004;200:1001-1013.
30. Zhu M, Liu Y, Koonpaew S, Granillo O, Zhang W. Positive and negative regulation of Fcepsilon RI-mediated signaling by the adaptor protein LAB/NTAL. J Exp Med. 2004;200:991-1000.
31. Tomasello E, Desmoulins PO, Chemin K, et al. Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice. Immunity. 2000;13:355-364.
32. Kaifu T, Nakahara J, Inui M, et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest. 2003;111:323-332.
33. Nunez-Cruz S, Aguado E, Richelme S, et al. LAT regulates gammadelta T cell homeostasis and differentiation. Nat Immunol. 2003;4:999-1008.
34. Wang Y, Horvath O, Hamm-Baarke A, et al. Single and combined deletions of the NTAL/LAB and LAT adaptors minimally affect B cell development and function. Mol Cell Biol. 2005;25:4455-4465.
35. Diefenbach A, Jensen ER, Jamieson AM, Raulet DH. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 2001;413:165-171.
36. Shores EW, Ono M, Kawabe T, et al. T cell development in mice lacking all T cell receptor zeta family members (zeta, eta, and Fcepsilon RIgamma). J Exp Med. 1998;187:1093-1101.
37. Kim S, Iizuka K, Kang HS, et al. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol. 2002;3:523-528.
38. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Ann Rev Immunol. 1999;17:189-220.
39. Prlic M, Blazar BR, Farrar MA, Jameson SC. In vivo survival and homeostatic proliferation of natural killer cells. J Exp Med. 2003;197:967-976.
40. Jamieson AM, Isnard P, Dorfman JR, Coles MC, Raulet DH. Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J Immunol. 2004;172:864-870.
41. D5/D5 mice. Proc Natl Acad Sci U S A. 1995;92:7545-7549.
42. Smith HR, Heusel JW, Mehta IK, et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A. 2002;99:8826-8831.
43. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 2002;296:1323-1326.
44. Rosen DB, Araki M, Hamerman JA, Chen T, Yamamura T, Lanier LL. A structural basis for the association of DAP12 with mouse, but not human, NKG2D. J Immunol. 2004;173:2470-2478.
45. Zompi S, Hamerman JA, Ogasawara K, et al. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat Immunol. 2003;4:565-572.
46. Billadeau DD, Upshaw JL, Schoon RA, Dick CJ, Leibson PJ. NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Nat Immunol. 2003;4:557-564.
47. Bloch-Queyrat C, Fondaneche MC, Chen R, et al. Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn. J Exp Med. 2005;202:181-192.
48. Sivori S, Parolini S, Marcenaro E, et al. Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines. J Neuroimmunol. 2000;107:220-225.
49. Abi-Rached L, Parham P. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J Exp Med. 2005;201:1319-1332.
50. Andre P, Castriconi R, Espeli M, et al. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors. Eur J Immunol. 2004;34:961-971.
51. Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, Raulet DH. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity. 2002;17:19-29.
52. Bakker AB, Hoek RM, Cerwenka A, et al. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity. 2000;13:345-353.
53. Cella M, Fujikawa K, Tassi I, et al. Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. J Exp Med. 2004;200:817-823.
54. Gismondi A, Cifaldi L, Mazza C, et al. Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect. Blood. 2004;104:436-443.
55. Walzer T, Joubert G, Dubois PM, et al. Characterization at the single-cell level of naive and primed CD8 T cell cytokine responses. Cell Immunol. 2000;206:16-25.
56. Augugliaro R, Parolini S, Castriconi R, et al. Selective cross-talk among natural cytotoxicity receptors in human natural killer cells. Eur J Immunol. 2003;33:1235-1241.
57. Pende D, Cantoni C, Rivera P, et al. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol. 2001;31:1076-1086.
58. Saitoh S, Arudchandran R, Manetz TS, et al. LAT is essential for Fc(epsilon)RI-mediated mast cell activation. Immunity. 2000;12:525-535.
59. Salvador JM, Mittelstadt PR, Guszczynski T, et al. Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases. Nat Immunol. 2005;6:390-395.
60. Kohler F, Storch B, Kulathu Y, et al. A leucine zipper in the N terminus confers membrane association to SLP-65. Nat Immunol. 2005;6:204-210.
61. Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M. Phospholipase C-γ2 is a critical signaling mediator for murine NK cell activating receptors. J Immunol. 2005;175:749-754.
62. Upshaw JL, Schoon RA, Dick CJ, Billadeau DD, Leibson PJ. The isoforms of phospholipase C-γ are differentially used by distinct human NK activating receptors. J Immunol. 2005;175:213-218.
63. Stewart CA, Laugier-Anfossi F, Vély F, et al. Recognition of peptide-MHC class I complexes by activating killer cell immunoglobulin-like receptors. Proc Natl Acad Sci U S A. 2005;102:13224-13229.